KLF16 Affects the MYC Signature and Tumor Growth in Prostate Cancer

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Attard G, Parker C, Eeles RA, et al. Prostate cancer. Lancet. 2016;387(10013):70–82. doi:10.1016/S0140-6736(14)61947-426074382
   PubMed Web of Science ®Google Scholar
• Watson PA, Arora VK, Sawyers CL. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat Rev Cancer. 2015;15(12):701–711. doi:10.1038/nrc401626563462
   PubMed Web of Science ®Google Scholar
• Petrylak DP, Tangen CM, Hussain MH, et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 2004;351(15):1513–1520. doi:10.1056/NEJMoa04131815470214
   PubMed Web of Science ®Google Scholar
• Tannock IF, de Wit R, Berry WR, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med. 2004;351(15):1502–1512. doi:10.1056/NEJMoa04072015470213
   PubMed Web of Science ®Google Scholar
• Karantanos T, Evans CP, Tombal B, Thompson TC, Montironi R, Isaacs WB. Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level. Eur Urol. 2015;67(3):470–479. doi:10.1016/j.eururo.2014.09.04925306226
   PubMed Web of Science ®Google Scholar
• McConnell BB, Yang VW. Mammalian Kruppel-like factors in health and diseases. Physiol Rev. 2010;90(4):1337–1381. doi:10.1152/physrev.00058.200920959618
   PubMed Web of Science ®Google Scholar
• Tetreault MP, Yang Y, Katz JP. Kruppel-like factors in cancer. Nat Rev Cancer. 2013;13(10):701–713. doi:10.1038/nrc358224060862
   PubMed Web of Science ®Google Scholar
• Liu YN, Abou-Kheir W, Yin JJ, et al. Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor beta-initiated prostate cancer epithelial-mesenchymal transition. Mol Cell Biol. 2012;32(5):941–953. doi:10.1128/MCB.06306-1122203039
   PubMed Web of Science ®Google Scholar
• Narla G, Heath KE, Reeves HL, et al. KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science. 2001;294(5551):2563–2566. doi:10.1126/science.106632611752579
   PubMed Web of Science ®Google Scholar
• Narla G, DiFeo A, Yao S, et al. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. Cancer Res. 2005;65(13):5761–5768. doi:10.1158/0008-5472.CAN-05-021715994951
   PubMed Web of Science ®Google Scholar
• Benzeno S, Narla G, Allina J, et al. Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Res. 2004;64(11):3885–3891. doi:10.1158/0008-5472.CAN-03-281815172998
   PubMed Web of Science ®Google Scholar
• He HJ, Gu XF, Xu WH, Yang DJ, Wang XM, Su Y. Kruppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer. Acta Pharmacol Sin. 2013;34(2):282–288. doi:10.1038/aps.2012.13023023312
   PubMed Web of Science ®Google Scholar
• Shen P, Sun J, Xu G, et al. KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells. Prostate. 2014;74(9):946–958. doi:10.1002/pros.v74.924737412
   PubMed Web of Science ®Google Scholar
• Wang Q, Peng R, Wang B, et al. Transcription factor KLF13 inhibits AKT activation and suppresses the growth of prostate carcinoma cells. Cancer Biomark. 2018;22(3):533–541. doi:10.3233/CBM-18119629843216
   PubMed Web of Science ®Google Scholar
• Yu W, Li J, Wang Q, et al. Targeting POH1 inhibits prostate cancer cell growth and enhances the suppressive efficacy of androgen deprivation and docetaxel. Prostate. 2019;79(11):1304–1315. doi:10.1002/pros.v79.1131212367
   PubMed Web of Science ®Google Scholar
• Abeshouse A, Ahn J, Akbani R; Cancer Genome Atlas Research N. The molecular taxonomy of primary prostate cancer. Cell. 2015;163(4):1011–1025. doi:10.1016/j.cell.2015.10.02526544944
   PubMed Web of Science ®Google Scholar
• Taylor BS, Schultz N, Hieronymus H, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010;18(1):11–22. doi:10.1016/j.ccr.2010.05.02620579941
   PubMed Web of Science ®Google Scholar
• Cuzick J, Swanson GP, Fisher G, et al. Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. Lancet Oncol. 2011;12(3):245–255. doi:10.1016/S1470-2045(10)70295-321310658
   PubMed Web of Science ®Google Scholar
• Kumar A, Coleman I, Morrissey C, et al. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer. Nat Med. 2016;22(4):369–378. doi:10.1038/nm.405326928463
   PubMed Web of Science ®Google Scholar
• Hwang CK, D’Souza UM, Eisch AJ, et al. Dopamine receptor regulating factor, DRRF: a zinc finger transcription factor. Proc Natl Acad Sci USA. 2001;98(13):7558–7563. doi:10.1073/pnas.12163579811390978
   PubMed Web of Science ®Google Scholar
• Daftary GS, Lomberk GA, Buttar NS, et al. Detailed structural-functional analysis of the Kruppel-like factor 16 (KLF16) transcription factor reveals novel mechanisms for silencing Sp/KLF sites involved in metabolism and endocrinology. J Biol Chem. 2012;287(10):7010–7025. doi:10.1074/jbc.M111.26600722203677
   PubMed Web of Science ®Google Scholar
• Chen X, Li S, Ke Y, et al. KLF16 suppresses human glioma cell proliferation and tumourigenicity by targeting TFAM. Artif Cells Nanomed Biotechnol. 2018;46(sup1):608–615. doi:10.1080/21691401.2018.143165429374989
   PubMed Web of Science ®Google Scholar
• Ma P, Sun CQ, Wang YF, et al. KLF16 promotes proliferation in gastric cancer cells via regulating p21 and CDK4. Am J Transl Res. 2017;9(6):3027–3036.28670390
   PubMed Web of Science ®Google Scholar
• Dang CV. MYC on the path to cancer. Cell. 2012;149(1):22–35. doi:10.1016/j.cell.2012.03.00322464321
   PubMed Web of Science ®Google Scholar
• Bretones G, Delgado MD, Leon J. Myc and cell cycle control. Biochim Biophys Acta. 2015;1849(5):506–516. doi:10.1016/j.bbagrm.2014.03.01324704206
   PubMed Web of Science ®Google Scholar